Pfizer Inc and Germany's BioNTech SE are expected to soon submit an emergency use authorisation request to the US Food and Drug Administration (FDA) for vaccines for children aged six months to five years, the Washington Post has reported.
Coronavirus vaccines for children younger than five could be available as soon as end-February under a plan that would lead to the potential authorisation of a two-shot regimen in the coming weeks, the Post reported, citing people briefed on the situation.
The report says that the FDA urged the companies to submit the application so that regulators could begin reviewing the two-shot data.
Read more from Reuters here.
